Sickle Cell Disease Nephropathy: An Update on Risk Factors and Potential Biomarkers in Pediatric Patients

References

• Nath KA , HebbelRP. Sickle cell disease: renal manifestations and mechanisms. Nat. Rev. Nephrol.11(3), 161–171 (2015).
   PubMed Web of Science ®Google Scholar
• Hariri E , MansourA, ElAlam A, DaaboulY, KorjianS, BahousSA. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int. Urol. Nephrol.50(6), 1075–1083 (2018).
   PubMed Web of Science ®Google Scholar
• Hebbel RP . Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood77(2), 214–237 (1991).
   PubMed Web of Science ®Google Scholar
• Hebbel RP . Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium. J. Clin. Invest.99(11), 2561–2564 (1997).
   PubMed Web of Science ®Google Scholar
• Hebbel RP . Ischemia-reperfusion injury in sickle cell anemia: relationship to acute chest syndrome, endothelial dysfunction, arterial vasculopathy, and inflammatory pain. Hematol. Oncol. Clin. North Am.28(2), 181–198 (2014).
   PubMed Web of Science ®Google Scholar
• Nath KA , KatusicZS, GladwinMT. The perfusion paradox and vascular instability in sickle cell disease. Microcirculation11(2), 179–193 (2004).
   PubMed Web of Science ®Google Scholar
• Da Silva GB Jr , LiborioAB, DaherEde F. New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy. Ann. Hematol.90(12), 1371–1379 (2011).
   PubMed Web of Science ®Google Scholar
• Becker AM . Sickle cell nephropathy: challenging the conventional wisdom. Pediatr. Nephrol.26(12), 2099–2109 (2011).
   PubMed Web of Science ®Google Scholar
• Allon M , LawsonL, EckmanJR, DelaneyV, BourkeE. Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int.34(4), 500–506 (1988).
   PubMed Web of Science ®Google Scholar
• De Jong PE , SalehAW, DeZeeuw Det al. Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity? Clin. Nephrol. 22(4), 212–213 (1984).
   PubMed Web of Science ®Google Scholar
• Guasch A , CuaM, MitchWE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int.49(3), 786–791 (1996).
   PubMed Web of Science ®Google Scholar
• Schmitt F , MartinezF, BrilletGet al. Early glomerular dysfunction in patients with sickle cell anemia. Am. J. Kidney Dis.32(2), 208–214 (1998).
   PubMed Web of Science ®Google Scholar
• Wesson DE . The initiation and progression of sickle cell nephropathy. Kidney Int.61(6), 2277–2286 (2002).
   PubMed Web of Science ®Google Scholar
• Hostetter TH . Hyperfiltration and glomerulosclerosis. Semin. Nephrol.23(2), 194–199 (2003).
   PubMed Web of Science ®Google Scholar
• Platt OS , BrambillaDJ, RosseWFet al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med.330(23), 1639–1644 (1994).
   PubMed Web of Science ®Google Scholar
• Sharpe CC , TheinSL. How I treat renal complications in sickle cell disease. Blood123(24), 3720–3726 (2014).
   PubMed Web of Science ®Google Scholar
• Hirschberg R . Glomerular hyperfiltration in sickle cell disease. Clin. J. Am. Soc. Nephrol.5(5), 748–749 (2010).
   PubMed Web of Science ®Google Scholar
• Lebensburger JD , AbanI, PernellBet al. Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy. Am. J. Hematol.94(4), 417–423 (2019).
   PubMed Web of Science ®Google Scholar
• Audard V , BartolucciP, StehleT. Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy. Clin. Kidney J10(4), 475–478 (2017).
   PubMed Web of Science ®Google Scholar
• Wang WC , WareRE, MillerSTet al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet377(9778), 1663–1672 (2011).
   PubMed Web of Science ®Google Scholar
• Sharpe CC , TheinSL. Sickle cell nephropathy – a practical approach. Br. J. Haematol.155(3), 287–297 (2011).
   PubMed Web of Science ®Google Scholar
• Wigfall DR , WareRE, BurchinalMR, KinneyTR, ForemanJW. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J. Pediatr.136(6), 749–753 (2000).
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR , DabbaghS, AtiyehB, SimpsonP, SarnaikS. Prevalence of microalbuminuria in children with sickle cell disease. Pediatr. Nephrol.12(6), 475–478 (1998).
   PubMed Web of Science ®Google Scholar
• Guasch A , NavarreteJ, NassK, ZayasCF. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J. Am. Soc. Nephrol.17(8), 2228–2235 (2006).
   PubMed Web of Science ®Google Scholar
• Powars DR , ChanLS, HitiA, RamiconeE, JohnsonC. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine84(6), 363–376 (2005).
   PubMed Web of Science ®Google Scholar
• Powars DR , Elliott-MillsDD, ChanLet al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann. Intern. Med.115(8), 614–620 (1991).
   PubMed Web of Science ®Google Scholar
• Wolf RB , KassimAA, GoodpasterRL, DebaunMR. Nocturnal enuresis in sickle cell disease. Expert Rev. Hematol.7(2), 245–254 (2014).
   PubMed Web of Science ®Google Scholar
• De Jong PE , StatiusVan Eps LW. Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int.27(5), 711–717 (1985).
   PubMed Web of Science ®Google Scholar
• Scheinman JI . Sickle cell nephropathy. Pediatr. Nephrol.908–919 (1994).
   Google Scholar
• Alhwiesh A . An update on sickle cell nephropathy. Saudi J. Kidney Dis. Transpl.25(2), 249–265 (2014).
   PubMedGoogle Scholar
• de Santis Feltran L , deAbreu Carvalhaes JT, SessoR. Renal complications of sickle cell disease: managing for optimal outcomes. Paediatr. Drugs4(1), 29–36 (2002).
   PubMedGoogle Scholar
• Saborio P , ScheinmanJI. Sickle cell nephropathy. J. Am. Soc. Nephrol.10(1), 187–192 (1999).
   PubMed Web of Science ®Google Scholar
• Van Eps LWS , Pinedo-VeelsC, DeVries GH, DeKoning J. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet1(7644), 450–452 (1970).
   PubMed Web of Science ®Google Scholar
• Scheinman JI . Sickle cell disease and the kidney. Nat. Clin. Pract. Nephrol.5(2), 78–88 (2009).
   PubMedGoogle Scholar
• Baig MA , LinYS, RasheedJ, MittmanN. Renal medullary carcinoma. J. Natl. Med. Assoc.98(7), 1171–1174 (2006).
   PubMed Web of Science ®Google Scholar
• Pandya KK , KoshyM, BrownN, PresmanD. Renal papillary necrosis in sickle cell hemoglobinopathies. J. Urol.115(5), 497–501 (1976).
   PubMed Web of Science ®Google Scholar
• Zayas CF , PlattJ, EckmanJR. Prevalence and predictors of glomerular involvement in sickle cell anemia. J. Am. Soc. Nephrol.7(9), A0780 (1996).
   PubMed Web of Science ®Google Scholar
• Yeruva SL , PaulY, OnealP, NouraieM. Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay. Hemoglobin40(5), 295–299 (2016).
   PubMed Web of Science ®Google Scholar
• Sklar AH , PerezJC, HarpRJ, CaruanaRJ. Acute renal failure in sickle cell anemia. Int. J. Artif. Organs13(6), 347–351 (1990).
   PubMed Web of Science ®Google Scholar
• Gargiulo R , PandyaM, SebaA, HaddadRY, LermaEV. Sickle cell nephropathy. Dis. Mon.60(10), 494–499 (2014).
   PubMed Web of Science ®Google Scholar
• McPherson Yee M , JabbarSF, OsunkwoIet al. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin. J. Am. Soc. Nephrol.6(11), 2628–2633 (2011).
   PubMed Web of Science ®Google Scholar
• Stallworth JR , TripathiA, JerrellJM. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease. South. Med. J.104(11), 752–756 (2011).
   PubMed Web of Science ®Google Scholar
• Alvarez O , Lopez-MitnikG, ZillerueloG. Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr. Blood Cancer50(6), 1236–1239 (2008).
   PubMed Web of Science ®Google Scholar
• Elmariah H , GarrettME, DeCastro LMet al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am. J. Hematol.89(5), 530–535 (2014).
   PubMed Web of Science ®Google Scholar
• Drawz P , AyyappanS, NouraieMet al. Kidney disease among patients with sickle cell disease, hemoglobin SS and SC. Clin. J. Am. Soc. Nephrol.11(2), 207–215 (2016).
   PubMed Web of Science ®Google Scholar
• Thrower A , CicconeEJ, MaitraP, DerebailVK, CaiJ, AtagaKI. Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease. Br. J. Haematol.184(2), 246– 252 (2018).
   PubMed Web of Science ®Google Scholar
• McClellan AC , LuthiJC, LynchJRet al. High one year mortality in adults with sickle cell disease and end-stage renal disease. Br. J. Haematol.159(3), 360–367 (2012).
   PubMed Web of Science ®Google Scholar
• Haymann JP , HammoudiN, StankovicStojanovic Ket al. Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients. Br. J. Haematol.179(5), 820–828 (2017).
   PubMed Web of Science ®Google Scholar
• Foucan L , BourhisV, BangouJ, MeraultL, Etienne-JulanM, SalmiRL. A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia. Am. J. Med.104(4), 339–342 (1998).
   PubMed Web of Science ®Google Scholar
• Lottenberg R , HassellKL. An evidence-based approach to the treatment of adults with sickle cell disease. ASH Education Book2005(1), 58– 65 (2005).
   Google Scholar
• Yawn BP , BuchananGR, Afenyi-AnnanANet al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA312(10), 1033–1048 (2014).
   PubMed Web of Science ®Google Scholar
• Pham PT , PhamPC, WilkinsonAH, LewSQ. Renal abnormalities in sickle cell disease. Kidney Int.57(1), 1–8 (2000).
   PubMed Web of Science ®Google Scholar
• McKie KT , HanevoldCD, HernandezC, WallerJL, OrtizL, McKieKM. Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease. J. Pediatr. Hematol. Oncol.29(3), 140–144 (2007).
   PubMed Web of Science ®Google Scholar
• Falk RJ , ScheinmanJ, PhillipsG, OrringerE, JohnsonA, JennetteJC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N. Engl. J. Med.326(14), 910–915 (1992).
   PubMed Web of Science ®Google Scholar
• Alvarez O , MontaneB, LopezG, WilkinsonJ, MillerT. Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr. Blood Cancer47(1), 71–76 (2006).
   PubMed Web of Science ®Google Scholar
• Wood JC , CohenAR, PresselSLet al. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. Br. J. Haematol.172(1), 122–130 (2016).
   PubMed Web of Science ®Google Scholar
• Rodrigues PC , NortonRC, MuraoM, JanuarioJN, VianaMB. Iron deficiency in Brazilian infants with sickle cell disease. J. Pediatr.87(5), 405–411 (2011).
   Google Scholar
• Aygun B , MortierNA, SmeltzerMP, ShulkinBL, HankinsJS, WareRE. Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia. Am. J. Hematol.88(2), 116–119 (2013).
   PubMed Web of Science ®Google Scholar
• Fitzhugh CD , WigfallDR, WareRE. Enalapril and hydroxyurea therapy for children with sickle nephropathy. Pediatr. Blood Cancer45(7), 982–985 (2005).
   PubMed Web of Science ®Google Scholar
• Abbott KC , HypoliteIO, AgodoaLY. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin. Nephrol.58(1), 9–15 (2002).
   PubMed Web of Science ®Google Scholar
• Zahr RS , ChappaP, YinH, BrownLA, AtagaKI, ArcherDR. Renal protection by atorvastatin in a murine model of sickle cell nephropathy. Br. J. Haematol.181(1), 111– 121 (2018).
   PubMed Web of Science ®Google Scholar
• Kasztan M , FoxBM, SpeedJSet al. Long-term endothelin-a receptor antagonism provides robust renal protection in humanized sickle cell disease mice. J. Am. Soc. Nephrol.28(8), 2443–2458 (2017).
   PubMed Web of Science ®Google Scholar
• Tharaux PL , HagegeI, PlacierSet al. Urinary endothelin-1 as a marker of renal damage in sickle cell disease. Nephrol. Dial. Transplant.20(11), 2408–2413 (2005).
   PubMed Web of Science ®Google Scholar
• Sabaa N , DeFranceschi L, BonninPet al. Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J. Clin. Invest.118(5), 1924–1933 (2008).
   PubMed Web of Science ®Google Scholar
• Fox BM , KasztanM. Endothelin receptor antagonists in sickle cell disease: a promising new therapeutic approach. Life Sci.159, 15–19 (2016).
   PubMed Web of Science ®Google Scholar
• Ataga KI , BrittainJE, MooreDet al. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1. Eur. J. Haematol.85(3), 257–263 (2010).
   PubMed Web of Science ®Google Scholar
• Becton LJ , KalpatthiRV, RackoffEet al. Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr. Nephrol.25(8), 1505–1511 (2010).
   PubMed Web of Science ®Google Scholar
• Gurkan S , ScarponiKJ, HotchkissH, SavageB, DrachtmanR. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr. Nephrol.25(10), 2123–2127 (2010).
   PubMed Web of Science ®Google Scholar
• Maier-Redelsperger M , LevyP, LionnetFet al. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia. Blood Cells Mol. Dis.45(4), 289–292 (2010).
   PubMed Web of Science ®Google Scholar
• Day TG , DrasarER, FulfordT, SharpeCC, TheinSL. Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica97(2), 201–205 (2012).
   PubMed Web of Science ®Google Scholar
• Diwan BA , GladwinMT, NoguchiCT, WardJM, FitzhughAL, BuzardGS. Renal pathology in hemizygous sickle cell mice. Toxicol. Pathol30(2), 254–262 (2002).
   PubMed Web of Science ®Google Scholar
• Zatz R , BaylisC. Chronic nitric oxide inhibition model six years on. Hypertension32(6), 958–964 (1998).
   PubMed Web of Science ®Google Scholar
• Thompson J , ReidM, HambletonI, SerjeantGR. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Arch. Intern. Med.167(7), 701–708 (2007).
   PubMedGoogle Scholar
• Laurin LP , NachmanPH, DesaiPC, AtagaKI, DerebailVK. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease. Nephrol. Dial. Transplant.29(6), 1211–1218 (2014).
   PubMed Web of Science ®Google Scholar
• Bolarinwa RA , AkinladeKS, KutiMA, OlawaleOO, AkinolaNO. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors. Saudi J. Kidney Dis. Transpl.23(1), 171–175 (2012).
   PubMedGoogle Scholar
• Iwalokun BA , IwalokunSO, HodonuSO, AinaOA, AgomoPU. Evaluation of microalbuminuria in relation to asymptomatic bacteruria in Nigerian patients with sickle cell anemia. Saudi J. Kidney Dis. Transpl.23(6), 1320–1330 (2012).
   PubMedGoogle Scholar
• De Castro LM , JonassaintJC, GrahamFL, Ashley-KochA, TelenMJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am. J. Hematol.83(1), 19–25 (2008).
   PubMed Web of Science ®Google Scholar
• Forrest S , KimA, CarbonellaJ, PashankarF. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease. Pediatr. Blood Cancer58(6), 937–940 (2012).
   PubMed Web of Science ®Google Scholar
• Rees DC , GibsonJS. Biomarkers in sickle cell disease. Br. J. Haematol.156(4), 433–445 (2012).
   PubMed Web of Science ®Google Scholar
• Alvarez O , ZillerueloG, WrightD, MontaneB, Lopez-MitnikG. Serum cystatin C levels in children with sickle cell disease. Pediatr. Nephrol.21(4), 533–537 (2006).
   PubMed Web of Science ®Google Scholar
• Zahr RS , RampersaudE, KangGet al. Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life. Haematologica doi:10.3324/haematol.2018.212779 (2019) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Belisario AR , VieiraELM, DeAlmeida JAet al. Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia. Br. J. Haematol.185(1), 190–193 (2019).
   PubMed Web of Science ®Google Scholar
• Heimlich JB , ChipokaG, ElsherifLet al. Nephrin as a biomarker of sickle cell glomerulopathy in Malawi. Pediatr. Blood Cancer65(6), e26993 (2018).
   PubMed Web of Science ®Google Scholar
• Lebensburger JD , CutterGR, HowardTH, MuntnerP, FeigDI. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. Pediatr. Nephrol.32(9), 1565–1573 (2017).
   PubMed Web of Science ®Google Scholar
• Itokua KE , MakuloJR, LepiraFBet al. Albuminuria, serum antioxidant enzyme levels and markers of hemolysis and inflammation in steady state children with sickle cell anemia. BMC Nephrol.17(1), 178 (2016).
   PubMedGoogle Scholar
• Ghobrial EE , Abdel-AzizHA, KaddahAM, MubarakNA. Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr. Neonatol.57(3), 174–180 (2016).
   PubMed Web of Science ®Google Scholar
• Youssry I , MakarS, FawzyRet al. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1). Pediatr. Nephrol.30(12), 2163–2168 (2015).
   PubMed Web of Science ®Google Scholar
• Aloni MN , NgiyuluRM, Gini-EhunguJLet al. Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings. PLoS ONE9(5), e96561 (2014).
   PubMed Web of Science ®Google Scholar
• Badr M , ElKoumi MA, AliYFet al. Renal tubular dysfunction in children with sickle cell haemoglobinopathy. Nephrology18(4), 299–303 (2013).
   PubMed Web of Science ®Google Scholar
• Mohtat D , ThomasR, DuZet al. Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr. Nephrol.26(2), 275–280 (2011).
   PubMed Web of Science ®Google Scholar
• Lebensburger J , JohnsonSM, AskenaziDJ, RozarioNL, HowardTH, HilliardLM. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am. J. Hematol.86(5), 430–432 (2011).
   PubMed Web of Science ®Google Scholar
• King L , MoosangM, MillerM, ReidM. Prevalence and predictors of microalbuminuria in Jamaican children with sickle cell disease. Arch. Dis. Child96(12), 1135–1139 (2011).
   PubMed Web of Science ®Google Scholar
• Imuetinyan BA , OkoegualeMI, EgberueGO. Microalbuminuria in children with sickle cell anemia. Saudi J. Kidney Dis. Transpl.22(4), 733–738 (2011).
   PubMedGoogle Scholar
• Aygun B , MortierNA, SmeltzerMP, HankinsJS, WareRE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatr. Nephrol.26(8), 1285–1290 (2011).
   PubMed Web of Science ®Google Scholar
• Marsenic O , CoulouresKG, WileyJM. Proteinuria in children with sickle cell disease. Nephrol. Dial. Transplant.23(2), 715–720 (2008).
   PubMed Web of Science ®Google Scholar
• McBurney PG , HanevoldCD, HernandezCM, WallerJL, McKieKM. Risk factors for microalbuminuria in children with sickle cell anemia. J. Pediatr. Hematol. Oncol.24(6), 473–477 (2002).
   PubMed Web of Science ®Google Scholar
• Datta V , AyengarJR, KarpateS, ChaturvediP. Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease. Indian J. Pediatr.70(4), 307–309 (2003).
   PubMedGoogle Scholar
• Geard A , PuleGD, ChetchaChemegni Bet al. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br. J. Haematol.178(4), 629–639 (2017).
   PubMed Web of Science ®Google Scholar
• Ephraim RK , OsakunorDN, CudjoeOet al. Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana. BMC Nephrol.16, 75 (2015).
   PubMedGoogle Scholar
• Hamideh D , RajV, HarringtonTet al. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr. Nephrol.29(10), 1997–2003 (2014).
   PubMed Web of Science ®Google Scholar
• Alkhunaizi AM , Al-KhattiAA. Proteinuria in patients with sickle cell disease. Saudi J. Kidney Dis. Transpl.25(5), 1038–1041 (2014).
   PubMedGoogle Scholar
• Sundaram N , BennettM, WilhelmJet al. Biomarkers for early detection of sickle nephropathy. Am. J. Hematol.86(7), 559–566 (2011).
   PubMed Web of Science ®Google Scholar
• Arogundade FA , SanusiAA, HassanMO, SalawuL, DurosinmiMA, AkinsolaA. An appraisal of kidney dysfunction and its risk factors in patients with sickle cell disease. Nephron. Clin. Pract.118(3), c225–c231 (2011).
   PubMedGoogle Scholar
• Emokpae MA , UadiaPO, GadzamaAA. Correlation of oxidative stress and inflammatory markers with the severity of sickle cell nephropathy. Ann. Afr. Med.9(3), 141–146 (2010).
   PubMedGoogle Scholar
• Sesso R , AlmeidaMA, FigueiredoMS, BordinJO. Renal dysfunction in patients with sickle cell anemia or sickle cell trait. Braz. J. Med. Biol. Res.31(10), 1257–1262 (1998).
   PubMed Web of Science ®Google Scholar
• Ataga KI , DerebailVK, ArcherDR. The glomerulopathy of sickle cell disease. Am. J. Hematol.89(9), 907–914 (2014).
   PubMed Web of Science ®Google Scholar
• Alvarez O , MillerST, WangWCet al. Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr. Blood Cancer59(4), 668–674 (2012).
   PubMed Web of Science ®Google Scholar
• Arlet JB , RibeilJA, ChatellierGet al. Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study. BMC Nephrol.13, 83 (2012).
   PubMed Web of Science ®Google Scholar
• Lippi G , DeFranceschi L, SalvagnoGL, MontagnanaM, GuidiGC. Estimation of glomerular filtration rate by the modification of diet in renal disease (MDRD) equation in patients with sickle cell disease. Clin. Chem. Lab. Med.46(8), 1200–1201 (2008).
   PubMed Web of Science ®Google Scholar
• Barros FB , LimaCS, SantosAOet al. 51Cr-EDTA measurements of the glomerular filtration rate in patients with sickle cell anaemia and minor renal damage. Nucl. Med. Commun.27(12), 959–962 (2006).
   PubMed Web of Science ®Google Scholar
• Bayazit AK , NoyanA, AldudakBet al. Renal function in children with sickle cell anemia. Clin. Nephrol.57(2), 127–130 (2002).
   PubMed Web of Science ®Google Scholar
• Asnani M , SerjeantG, Royal-ThomasT, ReidM. Predictors of renal function progression in adults with homozygous sickle cell disease. Br. J. Haematol.173(3), 461–468 (2016).
   PubMed Web of Science ®Google Scholar
• Lebensburger JD , CutterGR, HowardTH, MuntnerP, FeigDI. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. Pediatr. Nephrol.32(9), 1565–1573 (2017).
   PubMed Web of Science ®Google Scholar
• Nath KA , CroattAJ, HaggardJJ, GrandeJP. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int.57(6), 2423–2433 (2000).
   PubMed Web of Science ®Google Scholar
• Emokpae MA , UadiaPO. Association of oxidative stress markers with atherogenic index of plasma in adult sickle cell nephropathy. Anemia2012, 767501 (2012).
   PubMedGoogle Scholar
• Belcher JD , ChenC, NguyenJet al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood123(3), 377–390 (2014).
   PubMed Web of Science ®Google Scholar
• Tracz MJ , AlamJ, NathKA. Physiology and pathophysiology of heme: implications for kidney disease. J. Am. Soc. Nephrol.18(2), 414–420 (2007).
   PubMed Web of Science ®Google Scholar
• Dos Santos TE , GoncalvesRP, BarbosaMC, Da SilvaGBJr, DaherEde F. Monocyte chemoatractant protein-1: a potential biomarker of renal lesion and its relation with oxidative status in sickle cell disease. Blood Cells Mol. Dis.54(3), 297–301 (2015).
   PubMed Web of Science ®Google Scholar
• Garibotto G , CartaA, PicciottoD, ViazziF, VerzolaD. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy. J. Nephrol.30(6), 719–727 (2017).
   PubMed Web of Science ®Google Scholar
• Solovieff N , MiltonJN, HartleySWet al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster. Blood115(9), 1815–1822 (2010).
   PubMed Web of Science ®Google Scholar
• Gladwin MT , SchechterAN, OgnibeneFPet al. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation107(2), 271–278 (2003).
   PubMed Web of Science ®Google Scholar
• Rosse WF , GallagherD, KinneyTRet al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of sickle cell disease. Blood76(7), 1431–1437 (1990).
   PubMed Web of Science ®Google Scholar
• Wonkam A , MnikaK, NgoBitoungui VJet al. Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon. Br. J. Haematol.180(1), 134–146 (2018).
   PubMed Web of Science ®Google Scholar
• Asnani MR , ReidME. Renal function in adult Jamaicans with homozygous sickle cell disease. Hematology20(7), 422–428 (2015).
   PubMed Web of Science ®Google Scholar
• Asnani MR , FraserRA, ReidME. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease. PLoS ONE6(4), e18863 (2011).
   PubMed Web of Science ®Google Scholar
• Bodas P , HuangA, O'RiordanMA, SedorJR, DellKM. The prevalence of hypertension and abnormal kidney function in children with sickle cell disease – a cross sectional review. BMC Nephrol.14(1), 237 (2013).
   PubMedGoogle Scholar
• Anigilaje EA , AdedoyinOT. Correlation between dipstick urinalysis and urine sediment microscopy in detecting haematuria among children with sickle cell anaemia in steady state in Ilorin, Nigeria. Pan Afr. Med. J.15(1), 135 (2013).
   PubMedGoogle Scholar
• Gosmanova EO , ZaidiS, WanJY, Adams-GravesPE. Prevalence and progression of chronic kidney disease in adult patients with sickle cell disease. J. Investig. Med.62(5), 804–807 (2014).
   PubMed Web of Science ®Google Scholar
• Saraf SL , ZhangX, KaniasTet al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br. J. Haematol.164(5), 729–739 (2014).
   PubMed Web of Science ®Google Scholar
• Alkhunaizi AM , Al-KhattiAA, AlkhunaiziMA. Prevalence of microalbuminuria in adult patients with sickle cell disease in eastern Saudi Arabia. Int. J. Nephrol.2018, 5015764 (2018).
   PubMedGoogle Scholar
• Guasch A , ZayasCF, EckmanJR, MuralidharanK, ZhangW, ElsasLJ. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J. Am. Soc. Nephrol.10(5), 1014–1019 (1999).
   PubMed Web of Science ®Google Scholar
• Saraf SL , ShahBN, ZhangXet al. APOL1, alpha-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia. Haematologica102(1), e1–e6 (2017).
   PubMed Web of Science ®Google Scholar
• Koyner JL , VaidyaVS, BennettMRet al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin. J. Am. Soc. Nephrol.5(12), 2154–2165 (2010).
   PubMed Web of Science ®Google Scholar
• Bonventre JV , VaidyaVS, SchmouderR, FeigP, DieterleF. Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol.28(5), 436–440 (2010).
   PubMed Web of Science ®Google Scholar
• Hoffmann D , AdlerM, VaidyaVSet al. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol. Sci.116(1), 8–22 (2010).
   PubMed Web of Science ®Google Scholar
• Unal S , KotanC, DelibasA, OztasY. Cystatin C, beta2 microglobulin, N-acetyl-beta-D-glucosaminidase, retinol-binding protein, and endothelin 1 levels in the evaluation of sickle cell disease nephropathy. Pediatr. Hematol. Oncol.32(4), 250–257 (2015).
   PubMed Web of Science ®Google Scholar
• Saraf SL , ZhangX, ShahBet al. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica100(10), 1275–1284 (2015).
   PubMed Web of Science ®Google Scholar
• Martin CE , JonesN. Nephrin signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond. Front. Endocrinol.9, 302 (2018).
   PubMed Web of Science ®Google Scholar
• Humphreys BD , XuF, SabbisettiVet al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J. Clin. Invest.123(9), 4023–4035 (2013).
   PubMed Web of Science ®Google Scholar
• Bonventre JV . Kidney injury molecule-1: a translational journey. Trans. Am. Clin. Climatol. Assoc.125, 293–299 (2014).
   PubMedGoogle Scholar
• Maynard SE , MinJY, MerchanJet al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest.111(5), 649–658 (2003).
   PubMed Web of Science ®Google Scholar
• Kato GJ , PielFB, ReidCDet al. Sickle cell disease. Nat. Rev. Dis. Primers.4, 18010 (2018).
   PubMed Web of Science ®Google Scholar
• Sureshbabu A , RyterSW, ChoiME. Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol.4, 208–214 (2015).
   PubMed Web of Science ®Google Scholar
• Roy S , RaiP, EiymoMwa Mpollo MSet al. Angiotensin receptor signaling in sickle cell anemia has a reno-protective effect on urine concentrating ability but results in sickle glomerulopathy. Am. J. Hematol.93(7), E177–E181 (2018).
   PubMed Web of Science ®Google Scholar
• Nolan VG , MaQ, CohenHTet al. Estimated glomerular filtration rate in sickle cell anemia is associated with polymorphisms of bone morphogenetic protein receptor 1B. Am. J. Hematol.82(3), 179–184 (2007).
   PubMed Web of Science ®Google Scholar
• Ashley-Koch AE , OkochaEC, GarrettMEet al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br. J. Haematol.155(3), 386–394 (2011).
   PubMed Web of Science ®Google Scholar
• Naik RP , IrvinMR, JuddSet al. Sickle cell trait and the risk of ESRD in Blacks. J. Am. Soc. Nephrol.28(7), 2180–2187 (2017).
   PubMed Web of Science ®Google Scholar
• Kormann R , JannotAS, NarjozCet al. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br. J. Haematol.179(2), 323–335 (2017).
   PubMed Web of Science ®Google Scholar